EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pulmonary Alveolar Microlithiasis: From Clinicopathologic Description to Molecular Pathogenesis and Emerging Therapies

Kseniia Malkova, Mylene T. Truong, Cesar A. Moran

Journal of Respiration · 12.11.2026 · 6 (4) · 31

DOI: 10.3390/jor6040031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Respiration, online erschienen am 12.11.2026. Verfasst von Kseniia Malkova und 2 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive lung disease in which calcium phosphate microliths fill the alveoli; more than 1000 cases have been reported worldwide. Although its cause remained unknown for decades, loss-of-function variants in SLC34A2, which encodes the sodium-phosphate cotransporter NPT2b, are now known to explain nearly all genetically tested cases; failure to clear phosphate from the alveolar lining fluid leads to microlith formation, and an epithelial Npt2b-knockout mouse reproduces the human phenotype. Diagnosis now rests mainly on characteristic high-resolution CT and, increasingly, on genotyping rather than lung biopsy. The course is usually slow but variable; in published series followed for 10 to 49 years after diagnosis, a substantial proportion of patients, though not all, progressed to respiratory failure, whereas others remained stable for decades. No drug has proven efficacy; lung transplantation is the only established therapy for end-stage disease, and no allograft recurrence has been documented. Preclinical data support phosphate restriction, EDTA lavage and gene-directed approaches. However, controlled trials with more genotype–phenotype correlation and prospective natural-history data are still needed.

Zitieren

APA

Malkova, K., Truong, M. T., & Moran, C. A. (2026). Pulmonary Alveolar Microlithiasis: From Clinicopathologic Description to Molecular Pathogenesis and Emerging Therapies. Journal of Respiration, 6(4), 31. https://doi.org/10.3390/jor6040031

Vancouver

Malkova K, Truong MT, Moran CA. Pulmonary Alveolar Microlithiasis: From Clinicopathologic Description to Molecular Pathogenesis and Emerging Therapies. Journal of Respiration. 2026;6(4):31. doi:10.3390/jor6040031

BibTeX
@article{Malkova2026,
  author = {Malkova, Kseniia and Truong, Mylene T. and Moran, Cesar A.},
  title = {Pulmonary Alveolar Microlithiasis: From Clinicopathologic Description to Molecular Pathogenesis and Emerging Therapies},
  journal = {Journal of Respiration},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {31},
  doi = {10.3390/jor6040031}
}
Kostenlos starten →